Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Clinical trial NCT07153744 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07153744
Sponsor: Shanghai Hutchison Pharmaceuticals Limited
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Myocardial Infarction (AMI)Percutaneous Coronary Intervention (PCI)

Start date: 2025-09-01
Primary completion: 2028-12-01
Enrollment: 9588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.